Process View
The process in which the developmental fate of a cell becomes restricted such that it will develop into an epithelial cell.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "epithelial cell fate commitment"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RARA | retinoic acid receptor, alpha | 1.000 | Mouse | |
| NCOA1 | nuclear receptor coactivator 1 | 1.000 | ||
| RXRA | retinoid X receptor, alpha | 0.999 | Human | |
| MED25 | mediator complex subunit 25 | 0.999 | ||
| JAG1 | jagged 1 | 0.984 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.981 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.947 | Human | |
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.935 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.934 | ||
| NOTCH1 | notch 1 | 0.933 | Mouse | |
| NOTCH3 | notch 3 | 0.894 | ||
| BMP2 | bone morphogenetic protein 2 | 0.889 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.779 | ||
| GDF5 | growth differentiation factor 5 | 0.746 | ||
| SMAD7 | SMAD family member 7 | 0.651 | ||
| PROX1 | prospero homeobox 1 | 0.600 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.556 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.553 | Human | |
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.550 | Human | |
| ACVR1 | activin A receptor, type I | 0.523 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.494 | ||
| SPOP | speckle-type POZ protein | 0.487 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.483 | Human | |
| FSTL1 | follistatin-like 1 | 0.419 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.400 | ||
| MAML1 | mastermind-like 1 (Drosophila) | 0.388 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.379 | ||
| ENG | endoglin | 0.350 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.324 | Zebrafish Mouse | |
| PTCH1 | patched 1 | 0.322 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.251 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.242 | Human | |
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.202 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.194 | ||
| ATXN1L | ataxin 1-like | 0.190 | ||
| NRP1 | neuropilin 1 | 0.160 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.155 | ||
| RXRB | retinoid X receptor, beta | 0.144 | Human | |
| TBX5 | T-box 5 | 0.142 | ||
| SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.139 | ||
| KANK2 | KN motif and ankyrin repeat domains 2 | 0.129 | ||
| TAOK1 | TAO kinase 1 | 0.112 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.093 | ||
| NOTCH2 | notch 2 | 0.087 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.085 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.080 | ||
| HNF1A | HNF1 homeobox A | 0.077 | ||
| BMP4 | bone morphogenetic protein 4 | 0.076 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.068 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.064 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.063 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.062 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.058 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.053 | ||
| ZNF331 | zinc finger protein 331 | 0.050 | ||
| ACVR1B | activin A receptor, type IB | 0.043 | Human | |
| AXIN1 | axin 1 | 0.043 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.042 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.041 | ||
| KRT8 | keratin 8 | 0.040 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.040 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.038 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.038 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.037 | ||
| HOXA10 | homeobox A10 | 0.036 | ||
| CTBP2 | C-terminal binding protein 2 | 0.036 | ||
| RARG | retinoic acid receptor, gamma | 0.036 | ||
| PAX6 | paired box 6 | 0.035 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.034 | ||
| DHH | desert hedgehog | 0.034 | ||
| RXRG | retinoid X receptor, gamma | 0.033 | Human | |
| HNF1B | HNF1 homeobox B | 0.033 | ||
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.032 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.032 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.029 | ||
| KLF13 | Kruppel-like factor 13 | 0.029 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.027 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.027 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.027 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.026 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.026 | ||
| ITGB1BP2 | integrin beta 1 binding protein (melusin) 2 | 0.026 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.026 | ||
| HIPK3 | homeodomain interacting protein kinase 3 | 0.024 | ||
| PDGFC | platelet derived growth factor C | 0.024 | ||
| SMAD6 | SMAD family member 6 | 0.024 | ||
| SEMA4G | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G | 0.022 | ||
| PPL | periplakin | 0.022 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.021 | ||
| ZNF205 | zinc finger protein 205 | 0.021 | ||
| TADA3 | transcriptional adaptor 3 | 0.021 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.021 | ||
| FOXA2 | forkhead box A2 | 0.021 | ||
| ACVR2B | activin A receptor, type IIB | 0.021 | ||
| INHBB | inhibin, beta B | 0.021 | ||
| CIR1 | corepressor interacting with RBPJ, 1 | 0.020 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.020 | ||
| HOXA11 | homeobox A11 | 0.020 | ||
| CDX2 | caudal type homeobox 2 | 0.019 | ||
| ZNF579 | zinc finger protein 579 | 0.019 | ||
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.019 | ||
| LAMA5 | laminin, alpha 5 | 0.019 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.018 | ||
| ANTXR2 | anthrax toxin receptor 2 | 0.018 | ||
| FHL1 | four and a half LIM domains 1 | 0.018 | ||
| VIL1 | villin 1 | 0.017 | ||
| SOX13 | SRY (sex determining region Y)-box 13 | 0.017 | ||
| SART1 | squamous cell carcinoma antigen recognized by T cells | 0.017 | ||
| SMAD2 | SMAD family member 2 | 0.017 | ||
| MSX1 | msh homeobox 1 | 0.017 | ||
| HAP1 | huntingtin-associated protein 1 | 0.017 | ||
| TLE2 | transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) | 0.017 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.016 | ||
| GATA5 | GATA binding protein 5 | 0.016 | ||
| FOXC1 | forkhead box C1 | 0.016 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.016 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.016 | ||
| MNX1 | motor neuron and pancreas homeobox 1 | 0.016 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.016 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.016 | ||
| ZFPM2 | zinc finger protein, multitype 2 | 0.015 | ||
| HOXB13 | homeobox B13 | 0.015 | ||
| ONECUT1 | one cut homeobox 1 | 0.015 | ||
| GATA4 | GATA binding protein 4 | 0.015 | Mouse | |
| AGRN | agrin | 0.015 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.015 | ||
| HIC1 | hypermethylated in cancer 1 | 0.014 | ||
| HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 0.014 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.014 | ||
| ROBO2 | roundabout, axon guidance receptor, homolog 2 (Drosophila) | 0.014 | ||
| CCDC17 | coiled-coil domain containing 17 | 0.014 | ||
| PAX4 | paired box 4 | 0.013 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.013 | ||
| PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | 0.013 | ||
| PCDH18 | protocadherin 18 | 0.013 | ||
| ACVR2A | activin A receptor, type IIA | 0.013 | ||
| HOXA3 | homeobox A3 | 0.013 | ||
| FZD5 | frizzled homolog 5 (Drosophila) | 0.013 | ||
| NELL2 | NEL-like 2 (chicken) | 0.013 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.013 | ||
| NKX6-1 | NK6 homeobox 1 | 0.013 | ||
| NOG | noggin | 0.013 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.013 | ||
| CHGB | chromogranin B (secretogranin 1) | 0.013 | ||
| MYT1 | myelin transcription factor 1 | 0.013 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.013 | ||
| PTMS | parathymosin | 0.013 | ||
| DLL3 | delta-like 3 (Drosophila) | 0.013 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.013 | ||
| LRP12 | low density lipoprotein receptor-related protein 12 | 0.013 | ||
| ELAVL3 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) | 0.013 | ||
| ARX | aristaless related homeobox | 0.013 | Mouse | |
| JAG2 | jagged 2 | 0.012 | Mouse | |
| LTBP4 | latent transforming growth factor beta binding protein 4 | 0.012 | ||
| FGF9 | fibroblast growth factor 9 (glia-activating factor) | 0.012 | ||
| EPHB3 | EPH receptor B3 | 0.012 | ||
| HOXC12 | homeobox C12 | 0.012 | ||
| HIP1 | huntingtin interacting protein 1 | 0.012 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.012 | ||
| FOXD3 | forkhead box D3 | 0.012 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.012 | ||
| LHX2 | LIM homeobox 2 | 0.012 | ||
| USHBP1 | Usher syndrome 1C binding protein 1 | 0.012 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.012 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.012 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.012 | ||
| PGR | progesterone receptor | 0.012 | ||
| FOXD2 | forkhead box D2 | 0.012 | ||
| RARB | retinoic acid receptor, beta | 0.012 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.012 | ||
| ALX4 | ALX homeobox 4 | 0.012 | ||
| PITX2 | paired-like homeodomain 2 | 0.011 | ||
| HOXB7 | homeobox B7 | 0.011 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.011 | ||
| CELSR2 | cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) | 0.011 | ||
| PER1 | period homolog 1 (Drosophila) | 0.011 | ||
| IRX5 | iroquois homeobox 5 | 0.011 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.011 | ||
| CLDN11 | claudin 11 | 0.011 | ||
| HSD11B2 | hydroxysteroid (11-beta) dehydrogenase 2 | 0.011 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.011 | ||
| TACC1 | transforming, acidic coiled-coil containing protein 1 | 0.011 | ||
| HOXB8 | homeobox B8 | 0.011 | ||
| FGF18 | fibroblast growth factor 18 | 0.011 | ||
| INSM1 | insulinoma-associated 1 | 0.011 | ||
| PRKD2 | protein kinase D2 | 0.011 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.011 | ||
| CEP164 | centrosomal protein 164kDa | 0.011 | ||
| HOXD1 | homeobox D1 | 0.011 | ||
| IGSF1 | immunoglobulin superfamily, member 1 | 0.011 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.011 | ||
| LAMB1 | laminin, beta 1 | 0.011 | ||
| CSNK1E | casein kinase 1, epsilon | 0.011 | ||
| CLU | clusterin | 0.011 | ||
| MBNL2 | muscleblind-like 2 (Drosophila) | 0.011 | ||
| ONECUT2 | one cut homeobox 2 | 0.011 | ||
| HOXA2 | homeobox A2 | 0.011 | ||
| GAL3ST1 | galactose-3-O-sulfotransferase 1 | 0.011 | ||
| HOXA1 | homeobox A1 | 0.011 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.011 | ||
| RFX1 | regulatory factor X, 1 (influences HLA class II expression) | 0.011 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.011 | ||
| PMEL | premelanosome protein | 0.011 | ||
| PHACTR2 | phosphatase and actin regulator 2 | 0.011 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.011 | ||
| LTBR | lymphotoxin beta receptor (TNFR superfamily, member 3) | 0.011 | ||
| MMP15 | matrix metallopeptidase 15 (membrane-inserted) | 0.011 | ||
| LAPTM4A | lysosomal protein transmembrane 4 alpha | 0.011 | ||
| GDNF | glial cell derived neurotrophic factor | 0.011 | ||
| NPM3 | nucleophosmin/nucleoplasmin 3 | 0.011 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.011 | Human | |
| VTN | vitronectin | 0.010 | ||
| C19orf46 | chromosome 19 open reading frame 46 | 0.010 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.010 | ||
| MAGEA4 | melanoma antigen family A, 4 | 0.010 | ||
| BAMBI | BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) | 0.010 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.010 | ||
| GCM2 | glial cells missing homolog 2 (Drosophila) | 0.010 | ||
| TAF4 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | 0.010 | ||
| PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 0.010 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.010 | ||
| SIM2 | single-minded homolog 2 (Drosophila) | 0.010 | ||
| OCEL1 | occludin/ELL domain containing 1 | 0.010 | ||
| PRAME | preferentially expressed antigen in melanoma | 0.010 | ||
| ERF | Ets2 repressor factor | 0.010 | ||
| RUNDC3A | RUN domain containing 3A | 0.010 | ||
| FAM110C | family with sequence similarity 110, member C | 0.010 | ||
| GCG | glucagon | 0.010 | ||
| HOXD9 | homeobox D9 | 0.010 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.010 | ||
| SRI | sorcin | 0.010 | ||
| EPHB4 | EPH receptor B4 | 0.010 | ||
| TBX1 | T-box 1 | 0.010 | ||
| OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.010 | ||
| DLL4 | delta-like 4 (Drosophila) | 0.010 | ||
| NRTN | neurturin | 0.010 | ||
| C9orf96 | chromosome 9 open reading frame 96 | 0.010 | ||
| ESRRA | estrogen-related receptor alpha | 0.010 |